Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
2008
Gating the Selectivity Filter in ClC Chloride Channels
2003 StandoutScienceNobel
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay
2004 StandoutNobel
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
2016
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes
1998
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms
2007 StandoutNobel
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
2012
P‐glycoprotein is not a swelling‐activated Cl− channel; possible role as a Cl− channel regulator
1997
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Macromolecular crowding: obvious but underappreciated
2001 Standout
The biology of ovarian cancer: new opportunities for translation
2009
The Influence of Macromolecular Crowding and Macromolecular Confinement on Biochemical Reactions in Physiological Media
2001 Standout
Ovarian cancer
2014 Standout
Membrane protein folding
1999
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Targeting inflammation in diabetes: Newer therapeutic options
2014
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
2010
Clinical predictors of bevacizumab-associated gastrointestinal perforation
2010
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Cancer-associated cachexia
2018 Standout
Properties of volume-regulated anion channels in mammalian cells
1997
The biology of the P-glycoproteins
1995
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Hsp70 chaperones: Cellular functions and molecular mechanism
2005 Standout
Emerging cytokine networks in colorectal cancer
2015
P-glycoprotein—A mediator of multidrug resistance in tumour cells
1996
STAT3 in the systemic inflammation of cancer cachexia
2016
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study
2011
Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Adverse effects of anticancer agents that target the VEGF pathway
2009
Folding Kinetics and Structure of OEP16
2004 StandoutNobel
The basics of epithelial-mesenchymal transition
2009 Standout
Type 2 diabetes mellitus
2015 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
2012 Standout
LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength
2016 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Volume-activated Cl− channels
1996
Life cell quantification of mitochondrial membrane potential at the single organelle level
2007
Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor
1997
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
2007
Antibody-Mediated Encephalitis
2018 Standout
Structure of the human volume regulated anion channel
2018 StandoutNobel
Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient
2011 StandoutNobel
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis ofScutellaria baicalensis
2018
ACAT1 and ACAT2 Membrane Topology Segregates a Serine Residue Essential for Activity to Opposite Sides of the Endoplasmic Reticulum Membrane
2000
Targeting the JAK/STAT pathway in solid tumors
2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
2012 Standout
Evidence that fibroblasts derive from epithelium during tissue fibrosis
2002 Standout
Molecular Structure and Physiological Function of Chloride Channels
2002
Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: Implications for translocational regulation
2003
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Phosphatidylcholine and Phosphatidylethanolamine Behave as Substrates of the Human MDR1 P-Glycoprotein
1997
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Mitochondria and Apoptosis
1998 StandoutScience
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression
2017 StandoutNobel
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer
2011
Physiology of Microglia
2011 Standout
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
2015
Works of Ernest Han being referenced
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
2015
Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer
2017
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells
2014
Poorly Differentiated Colon Carcinoma With Neuroendocrine Features Presenting With Hypercalcemia and Cutaneous Metastases
2002
Bevacizumab in the treatment of ovarian cancer
2007
Role of the ribosome in sequence-specific regulation of membrane targeting and translocation of P-glycoprotein signal-anchor transmembrane segments
2000
Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer
2009
A Randomized Trial of a 6-Week Course of Celecoxib on Proteinuria in Diabetic Kidney Disease
2007
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
2006
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer
2010
Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
2014
Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
1994
Review: Practical considerations in ovarian cancer chemotherapy
2010
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
2018
Dissection of De Novo Membrane Insertion Activities of Internal Transmembrane Segments of ATP-Binding-Cassette Transporters: Toward Understanding Topological Rules for Membrane Assembly of Polytopic Membrane Proteins
1998
P-glycoprotein-associated chloride currents revealed by specific block by an anti-P-glycoprotein antibody
1996